CAS: 1030825-28-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | OP-1118 REF: TR-O662000CAS: 1030825-28-5 | - - - | 392.00 €~2,664.00 € | Tue 11 Mar 25 |
 | OP-1118 REF: 3D-FO71470CAS: 1030825-28-5 | Min. 95% | 324.00 €~2,817.00 € | Wed 12 Mar 25 |
 | OP-1118 REF: 4Z-F-076016CAS: 1030825-28-5 | - - - | - - - | Discontinued product |
OP-1118
Controlled ProductCAS:1030825-28-5
Applications OP-1118 is a major metabolite of Fidaxomicin (F335400). References Babakhani, F., et al.: J. …
Formula:
C48H68Cl2O17
Color and Shape:
Neat
Molecular weight:
987.95
Ref: TR-O662000
| 5mg | 392.00 € | ||
| 50mg | 2,664.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
OP-1118
CAS:1030825-28-5
OP-1118 is a small molecule that inhibits the activity of NF-κB, which is a major …
Formula:
C48H68Cl2O17
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
987.95 g/mol
Ref: 3D-FO71470
| 1mg | 324.00 € | ||
| 2mg | 456.00 € | ||
| 5mg | 725.00 € | ||
| 10mg | 1,315.00 € | ||
| 25mg | 2,817.00 € |
Estimated delivery in United States, on Wednesday 12 Mar 2025
Ref: 4Z-F-076016
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
